logo
welcome
Wired

Wired

Health

Health

Semaglutide, Novo Nordisk’s blockbuster diabetes drug, is no longer in shortage

Wired
Summary
Nutrition label

72% Informative

Semaglutide, the active ingredient in Novo Nordisk's Ozempic and Wegovy , has been on the FDA ’s shortage list since March 2022 .

In the intervening years , a lucrative industry of telehealth companies, medical spas, and pharmacies making and selling “compounded” copies of the medications.

These off-brand copies are sold at a steep discount—sometimes under $ 100 a vial—compared to the name-brand medications.

You’ve already got a whole population of compounders out there that are making it, the product quality is adequate, people are using it, and then you’re suddenly going to take it away? I mean, I think that that would create a public uproar.”.

VR Score

68

Informative language

71

Neutral language

22

Article tone

semi-formal

Language

English

Language complexity

63

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links